Revenues 86.3bn manats; total profit 12.6bn and net profit ~3.0bn. EBITDA rose 26%. Major field acquisitions and a 136% jump in operating cash flow.
Revenue driven by crude, petroleum and gas sales; EBITDA rose 26% and net profit ≈AZN 3.0bn amid major field acquisitions and stronger operating cash flow.
Exclusive agreement transfers market development and distribution of GMP-grade REXIM amino acids across most of Europe to a regional distributor, effective July 1, 2026.
Offer financing, policy, private‑sector tools and technical assistance to manage shocks to energy, food and trade — providing relief, budget support, liquidity, trade finance, firm support and resilience investments
STEP UP trial: early responders (≥15% at 24w) sustained major weight loss at 72w; higher dose reached goals faster than 2.4 mg; 84% of lost weight was fat and muscle function preserved.
Temporary surcharges on petrochemical products after crude/naphtha price spike from Middle East tensions and Hormuz blockade; reviewed regularly to secure supply.
Middle East conflict disrupts supply chains, raising raw material and logistics costs. Price hikes for polymer products start April 1, 2026, affecting European and Asian production sites.
The company aims to enhance growth, EBITDA margins, and cash flow, with a share repurchase program and strategic updates amid ongoing macroeconomic challenges.
Chevron and HELLENiQ ENERGY sign agreements for offshore exploration in Greece, focusing on seismic work to assess hydrocarbon potential. Awaiting Greek Parliament ratification.
Leviathan's gas capacity to increase to 21 BCM annually, boosting energy supply for Israel, Egypt, and Jordan. Completion expected by decade's end.
